Antibiotics for UTIs may disrupt gut bacteria, study finds
NCT ID NCT07424989
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how antibiotics used to treat urinary tract infections (UTIs) affect the bacteria in the gut. Researchers collected stool samples from 61 hospitalized patients before and after antibiotic treatment to see if resistant bacteria increased. The goal was to understand potential side effects of antibiotics on digestive health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- antibiotics (ceftriaxone, piperacillin/tazobactam, or temocillin)
- What this could lead to
- If successful, this could help doctors understand how antibiotic treatments for UTIs affect gut bacteria and the spread of antibiotic resistance.
- What could go wrong
- This is a small, completed observational study that does not test a new treatment. It only measures changes in gut bacteria, so it may not lead to direct clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
61 people
The number who actually took part.
- Started
-
Jul 2021
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients will be recruited via the Emergency Department (ED).
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patient requiring hospitalisation * Diagnosis of urinary tract infection requiring systemic antibiotic therapy with ceftriaxone, piperacillin/tazobactam or temocillin * Collection of a stool sample possible before or within 24 hours of starting systemic antibiotic therapy * Patient who has read and understood the information letter and given their consent to participate in the research Exclusion Criteria: * Minor patient * Patient hospitalised in an intensive care unit * Digestive stoma * Patient not affiliated with social security * Pregnant woman, woman in labour or breastfeeding woman * Person deprived of liberty by administrative or judicial decision * Person placed under judicial protection, guardianship or curatorship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Urinary tract infection(UTI) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Rouen
Rouen, 76031, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Bladder cocktail aims to stop recurrent UTIs in spinal cord injury
- VR training for future doctors: a new way to learn geriatric care?
- 500 patients join 5-Year quest to solve UTI mysteries
- Personalized antibiotic strategy aims to prevent deadly infections after kidney transplant
- Simple video could curb antibiotic overuse for UTIs
- Can extra cleaning with hydrogen peroxide or UV light slash ICU infections?